Screener
Royalty Pharma RPRX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $24.85B.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's market capitalization?
- Royalty Pharma (RPRX) reported market capitalization of $24.85B in Q2 2026.
- How has Royalty Pharma's market capitalization changed year-over-year?
- Royalty Pharma's market capitalization increased by 63.2% year-over-year, from $15.23B to $24.85B.
- What is the long-term trend for Royalty Pharma's market capitalization?
- Over 5 years (2020 to 2025), Royalty Pharma's market capitalization has grown at a -5.1% compound annual growth rate (CAGR), from $21.5B to $16.51B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Royalty Pharma's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude